VMH-26431-43946
3 vaccinations
12 coded responses
31 check-ins
6 free-text entries
2 call cases
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 200 / DC
- Registered
- 2022-06-23
- Relationship
- Child or adolescent in my care
- Guardian
- 3SK-69264-16710
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2022-06-23
Registered in v-safe
-
2022-06-23
Dose 1 — Moderna
- 2022-06-23
-
2022-06-24
Survey response — days 1–6 daily, dose 1, under 3MedDRA: Psychomotor hyperactivity — Feeling: Fair · Irritability/cryingFree text: Some hyperactivity. (Could be due to feeling tired.)MedDRA releases: 2024-11 · check-in free text available
- 2022-06-26
- 2022-06-28
- 2022-06-29
- 2022-06-30
-
2022-07-07
Survey response — day 14, dose 1, under 3MedDRA: Vomiting — Feeling: FairFree text: VomitingMedDRA releases: 2024-11 · check-in free text available
- 2022-07-14
-
2022-07-21
Dose 2 — Moderna
- 2022-07-21
-
2022-07-22
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Good · Site: Swelling/hardness · NoneUnder 3 check-in
-
2022-07-23
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Good · Site: Swelling/hardness · Fever · SleepinessUnder 3 check-in
-
2022-07-24
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Good · Site: Swelling/hardness · NoneUnder 3 check-in
-
2022-07-25
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Good · Site: Swelling/hardness · NoneUnder 3 check-in
-
2022-07-28
Survey response — day 7, dose 2, under 3MedDRA: Gastrooesophageal reflux disease — Feeling: Good · Irritability/cryingFree text: RefluxMedDRA releases: 2024-11 · check-in free text available
-
2022-08-04
Survey response — day 14, dose 2, under 3MedDRA: Respiratory tract congestion, Rhinorrhoea — Feeling: GoodFree text: Congestion, runny noseMedDRA releases: 2024-11 · check-in free text available
-
2022-08-11
Survey response — day 21, dose 2, under 3MedDRA: Respiratory tract congestion, Rhinorrhoea — Feeling: GoodFree text: Runny nose, congestion.MedDRA releases: 2024-11 · check-in free text available
- 2022-08-18
- 2022-08-27
- 2022-09-04
-
2022-10-24
Survey response — 3 months, dose 2, under 3MedDRA: Gastroenteritis viral, Rhinorrhoea — Feeling: GoodFree text: Various sniffles, tummy bugs and other normal toddler things.MedDRA releases: 2024-11 · check-in free text available
- 2023-01-24
-
2023-02-28
Dose 3 — Moderna
- 2023-02-28
-
2023-03-01
Health check-in — days 1–6 daily, dose 3, under 3Feeling: Good · Site: Pain · NoneUnder 3 check-in
-
2023-03-03
Survey response — days 1–6 daily, dose 3, under 3MedDRA: Restlessness — Feeling: Good · Site: PainMedDRA releases: 2024-11
-
2023-03-04
Survey response — days 1–6 daily, dose 3, under 3MedDRA: Nasopharyngitis — Feeling: GoodMedDRA releases: 2024-11
-
2023-03-05
Survey response — days 1–6 daily, dose 3, under 3MedDRA: Cough, Rhinorrhoea — Feeling: FairMedDRA releases: 2024-11
-
2023-03-09
Survey response — day 7, dose 3, under 3MedDRA: Middle insomnia, Rhinorrhoea — Feeling: GoodMedDRA releases: 2024-11
- 2023-03-30
- 2023-04-05
-
2023-04-11
Survey response — day 42, dose 3, under 3MedDRA: Pyrexia, Rhinorrhoea — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationMedDRA releases: 2024-11
-
2023-04-11
Report sent to call center — day 42, dose 3, under 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2023-04-12
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2023-06-01
Survey response — 3 months, dose 3, under 3MedDRA: Nasopharyngitis, Viral infection — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationMedDRA releases: 2024-11
- 2023-06-01
- 2023-06-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-23 | Moderna | No |
| 2 | 2022-07-21 | Moderna | No |
| 3 | 2023-02-28 | Moderna | No |
Call center
2 call center cases
1 successful · 1 unsuccessful
Free text
Release 12 (Under 3) — days 1–6 daily, dose 1, under 3
Systemic reaction (other): Some hyperactivity. (Could be due to feeling tired.)
Release 12 (Under 3) — day 14, dose 1, under 3
Symptoms: Vomiting
Release 12 (Under 3) — day 7, dose 2, under 3
Systemic reaction (other): Reflux
Release 12 (Under 3) — day 14, dose 2, under 3
Symptoms: Congestion, runny nose
Release 12 (Under 3) — day 21, dose 2, under 3
Symptoms: Runny nose, congestion.
Release 12 (Under 3) — 3 months, dose 2, under 3
Symptoms: Various sniffles, tummy bugs and other normal toddler things.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Gastroenteritis viral | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Viral infection | · | · | ✓ |
| SD | Vomiting | · | · | ✓ |
| SRO | Cough | · | · | ✓ |
| SRO | Gastrooesophageal reflux disease | · | · | ✓ |
| SRO | Middle insomnia | · | · | ✓ |
| SRO | Nasopharyngitis | · | · | ✓ |
| SRO | Psychomotor hyperactivity | · | · | ✓ |
| SRO | Restlessness | · | · | ✓ |
| SRO | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release